Clinical Hurdles of Pluripotent Stem Cell Therapy
Joseph C. Wu - Director, Stanford Cardiovascular Institute, Simon H. Stertzer, MD, Professor and Professor of Radiology
Bio-X Affiliated Faculty
Dr. Wu's lab works on biological mechanisms of adult stem cells, embryonic stem cells, and induced pluripotent stem cells.
Stanford Bio-X Seed Grants
New Engineering Tools for Investigating Cellular Reprogramming
Interdisciplinary Initiatives Program Round 7 - 2014
Other Stanford Bio-X Supported Research
Human induced pluripotent stem cell-derived cardiomyocytes for cardiac drug testing
Supported BioSTAR Sponsored Research Project - 2013
Research News
Stanford Medicine study discovers what’s behind heart cell damage from chemotherapy
November 27, 2024 - Stanford Medicine News Center
Stanford Bio-X faculty members Joseph Wu and Stanley Qi, with co-lead authors Drs. Chun Liu and...
Drug could alleviate side effects of chemo for breast cancer patients
March 14, 2019 - Stanford Medicine News Center
Researchers under Stanford Bio-X affiliated faculty Joseph Wu have found a way to predict who will...
Mouse model of human immune system inadequate for stem cell studies
August 22, 2017 - Stanford Medicine News Center
“Humanized” mice are used to study human immune responses, but they are inadequate for stem cell...